![Vitamin K antagonist vs direct oral anticoagulants with antiplatelet therapy in dual or triple therapy after percutaneous coronary intervention or acute coronary syndrome in atrial fibrillation: Meta‐analysis of randomized controlled trials]()
Vitamin K antagonist vs direct oral anticoagulants with antiplatelet therapy in dual or triple therapy after percutaneous coronary intervention or acute coronary syndrome in atrial fibrillation: Meta‐analysis of randomized controlled trialsRoule, Vincent; Ardouin, Pierre; Briet, Clément; Lemaitre, Adrien; Bignon, Mathieu; Sabatier, Rémi; Champ‐Rigot, Laure; Milliez, Paul; Blanchart, Katrien; Beygui, Farzin · Clinical Cardiology · 2019